{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:25:47Z","timestamp":1787772347617,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>This study aimed to evaluate the visual outcomes and associated factors in Omani patients with Behcet's disease (BD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODOLOGY:<\/jats:title>\n                    <jats:p>This is a descriptive retrospective analytical cohort study. All Omani patients of age 5\u201365 years with a confirmed clinical diagnosis of BD having ocular manifestation who attended the Rheumatology and Ophthalmology clinics at Sultan Qaboos University Hospital, Oman from January 2018 to October 2020. The demographic data, clinical findings, systemic, and ocular examination of all the recruited patients were retrieved from the electronic patient record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The study included 31 male and 16 female participants. The median age is 29.7 \u00b1 10.6 years. Most patients with ocular manifestations presented in the third decade of their life (21\u201330 years' age). The most common ocular manifestations in our study were uveitis (91.5%) followed by vitritis (40.4%), and retinal vasculitis (36.2%). The most common ocular complications in order of frequency were cataract (27.7%), posterior synechiae (23.4%), and cystoid macular edema (21.2%). In this study, 22.7% of the patients with BD-related ocular manifestations reported severe visual loss. In addition, when adding the patients with severe visual loss secondary to complications such as secondary glaucoma and optic nerve atrophy, the severe visual loss cumulatively reported being 50% for both groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The clinical characteristics of ocular manifestations in BD in Oman are similar to data from studies that have been conducted in other countries. However, our study found that the severity of ocular manifestations was more dominant among females. This study finding can be helpful for clinicians to predict ocular manifestations of BD to plan a timely follow-up and subsequently prevent further severe complications or visual loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ojo.ojo_68_22","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T13:49:17Z","timestamp":1716558557000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Visual outcomes and factors predictive of visual loss in Behcet's disease in Sultan Qaboos University Hospital, Oman"],"prefix":"10.4103","volume":"15","author":[{"given":"Nadiya","family":"Al Kharousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalfan Salim","family":"Khalfan Alnaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Almahrouqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washoo","family":"Mal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240908","first-page":"607921","article-title":"Diagnosis\/classification criteria for Behcet's disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Patholog Res Int"},{"key":"R2-3-20240908","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sjopt.2013.06.012","article-title":"Ocular manifestations of Beh\u00e7et's disease in Jordanian patients","volume":"27","author":"Abu-Ameerh","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"R3-3-20240908","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/ar757","article-title":"Beh\u00e7et's disease","volume":"5","author":"Hirohata","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"R4-3-20240908","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","article-title":"New insights in the clinical understanding of Beh\u00e7et's disease","volume":"53","author":"Cho","year":"2012","journal-title":"Yonsei Med J"},{"key":"R5-3-20240908","first-page":"271","article-title":"On a case of iritis with recurrent hypopyon","volume":"168","author":"Adamandiades","year":"1931","journal-title":"Ann Ocul"},{"key":"R6-3-20240908","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(08)60872-7","article-title":"Why rare diseases are an important medical and social issue","volume":"371","author":"Schieppati","year":"2008","journal-title":"Lancet"},{"key":"R7-3-20240908","first-page":"S96","article-title":"Beh\u00e7et's disease: Familial clustering and immunogenetics","volume":"23","author":"Fietta","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R8-3-20240908","first-page":"488","article-title":"Epidemiology of adamantiades-beh\u00e7et's disease","volume":"150","author":"Zouboulis","year":"1999","journal-title":"Ann Med Interne (Paris"},{"key":"R10-3-20240908","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular Sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clinics in Chest Medicine"},{"key":"R11-3-20240908","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R12-3-20240908","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/09273948.2020.1736310","article-title":"An algorithm for the diagnosis of beh\u00e7et disease uveitis in adults","volume":"29","author":"Tugal-Tutkun","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R13-3-20240908","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","article-title":"Ocular features of Behcet's disease: An international collaborative study","volume":"91","author":"Kitaichi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R15-3-20240908","doi-asserted-by":"crossref","first-page":"247345","DOI":"10.1155\/2013\/247345","article-title":"Behcet's disease: Systemic and ocular manifestations","volume":"2013","author":"Paovic","year":"2013","journal-title":"Biomed Res Int"},{"key":"R16-3-20240908","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","article-title":"Behcet's disease: From East to West","volume":"29","author":"Davatchi","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R17-3-20240908","first-page":"233","article-title":"Behcet'sDisease","volume":"43","author":"Davatchi","year":"2005","journal-title":"Acta Med Iran"},{"key":"R18-3-20240908","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0974-9233.58425","article-title":"Beh\u00e7et's Uveitis","volume":"16","author":"Tugal-Tutkun","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R19-3-20240908","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","article-title":"Beh\u00e7et disease: visual prognosis and factors influencing the development of visual loss","volume":"152","author":"Taylor","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R20-3-20240908","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0039-6257(82)90079-0","article-title":"Beh\u00e7et's disease","volume":"26","author":"Michelson","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"R21-3-20240908","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: An analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R22-3-20240908","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","article-title":"Clinical features of chinese patients with Beh\u00e7et's disease","volume":"115","author":"Yang","year":"2008","journal-title":"Ophthalmology"},{"key":"R23-3-20240908","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.10.1.53.10326","article-title":"Beh\u00e7et's disease in Western Switzerland: epidemiology and analysis of ocular involvement","volume":"10","author":"Ambresin","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-3-20240908","first-page":"339","article-title":"Beh\u00e7et's disease in Brazil \u2013 A review of 49 cases with emphasis on ophthalmic manifestations","volume":"35","author":"Barra","year":"1991","journal-title":"Jpn J Ophthalmol"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_68_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:40:09Z","timestamp":1787769609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_68_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_68_22","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}